MMedication Read More Medication cost prevents cancer patient from accessing treatmentMarch 9, 2026 GOSNELL, Ark. (KAIT) – Jen Holifield has multiple myeloma, an incurable blood cancer. Her doctor prescribed Lenalidomide —…
HHealth Read More Plain language summary of the management of certain side effects of teclistamab in people with multiple myelomaMarch 5, 2026 This Plain language summary of publication article, published in Future Oncology, provides a breakdown of the strategies used…
HHealth Read More Novel antibody blocks Epstein-Barr virus, curing follicular lymphoma — and a plan to reduce cancer in Washington stateMarch 4, 2026 SEATTLE – March 4, 2026 – Below are summaries of recent Fred Hutch Cancer Center research findings, patient…
HHealth Read More Common cardio drugs proven safe in myeloma patientsMarch 2, 2026 Commonly prescribed cardiovascular medications—such as statins, diuretics, and blood pressure drugs—appear to have little or no negative impact…
MMedication Read More FDA accepts BMS protein degrader for review; Disc rare disease drug rejectedFebruary 19, 2026 This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
HHealth Read More Why are men more likely to develop multiple myeloma than women?January 13, 2026 A study has unearthed potential reasons for sex differences that are observed in the clinical presentation of patients…
HHealth Read More Longest survival in the world reported to date for multiple myeloma patientsNovember 19, 2025 Berenson Cancer Center published survival data analyzed by the Institute for Myeloma & Bone Cancer Research of 175…
HHealth Read More Advances in diagnosis and management of systemic light chain amyloidosisOctober 30, 2025 Systemic light chain (AL) amyloidosis is a rare and life-threatening disorder characterized by the deposition of misfolded immunoglobulin…